Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 5Unspecified Adult Solid Tumor, Protocol Specific 3Solid Tumor, Adult 3Solid Tumor 2Pleural Effusion, Malignant 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Skin Neoplasms 1Select Advanced Solid Tumors 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Merkel Cell 1Carcinoma, Basal Cell 1Advanced Solid Tumors 1Advanced Refractory Solid Tumors 1Advanced Malignant Solid Tumor 1

Interventions

Injections 4Granulocyte-Macrophage Colony-Stimulating Factor 2Colony-Stimulating Factors 2nabiximols 1fludarabine 1camrelizumab 1Radiofrequency Ablation 1Interleukin-2 1Immune Checkpoint Inhibitors 1Cyclophosphamide 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Solid Tumor × Interleukin-2 × Other solid neoplasm × Clear all
NCT03171220 2017-06-06

NRT-01

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 1/2 Unknown
40 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡